324.81BMarket Cap142.49P/E (TTM)
128.930High126.190Low2.48MVolume126.710Open125.540Pre Close318.09MTurnover0.10%Turnover Ratio916.00P/E (Static)2.53BShares133.10052wk High8.05P/B324.00BFloat Cap97.80652wk Low3.00Dividend TTM2.53BShs Float133.100Historical High2.34%Div YieldTTM2.18%Amplitude18.229Historical Low128.180Avg Price1Lot Size
Merck & Co Stock Forum
⇨ $1.3B upfront payment & up to $1.7B in future milestone payments 💰
⇨ Includes Restoret™, novel late-phase candidate 👁️
» for diabetic macular edema and neovascular age-related macular degeneration
» enter pivotal study for DME in H2 2024
⇨ Deal to close in Q3 2024
Gapping up
$Marathon Oil(MRO.US)$ stock rose more than 7% following the announcement of being acquired by ConocoPhillips in a $17.1 billion all-stock deal.
$NVIDIA(NVDA.US)$ stock rose 0.4%, continuing to climb after the tech giant's hefty 7% gains the previous session.
$Dick's Sporting Goods(DKS.US)$ popped 7.7% after reporting an earnings and revenue beat for its fiscal first quarter and raising its full year gui...
$Merck & Co(MRK.US)$ $Bristol-Myers Squibb(BMY.US)$ $Johnson & Johnson(JNJ.US)$ $Pfizer(PFE.US)$ $Novo-Nordisk A/S(NVO.US)$ $AbbVie(ABBV.US)$
$Bristol-Myers Squibb(BMY.US)$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna(MRNA.US)$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals(CPRX.US)$ : FIRDAPSE® (Amifampridine)
$GlaxoSmithKline(GSK.US)$ : Arexvy
$Genfit(GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US)$ : Elafibranor
$Regeneron Pharmaceuticals(REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb(BMY.US)$ : Augtyro...
$Iovance Biotherapeutics(IOVA.US)$ Phase 2
$Supernus Pharmaceuticals(SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US)$ Phase 2a
$MorphoSys(MOR.US)$ Phase 2
$Nuvation Bio(NUVB.US)$ Phase 2
$ALX Oncology(ALXO.US)$ Phase 2
$BioXcel Therapeutics(BTAI.US)$ Phase 2
$Purple Biotech(PPBT.US)$ Phase 2
$Arcus Biosciences(RCUS.US)$ Phase 2
$Medicenna Therapeutics(MDNAF.US)$ Phase 2b
$Affimed NV(AFMD.US)$ Phase 2
$Barinthus Biotherapeutics(BRNS.US)$ Phase 2b...
$AbbVie(ABBV.US)$ +189%
$Bristol-Myers Squibb(BMY.US)$ +175%
$Johnson & Johnson(JNJ.US)$ +95%
$AstraZeneca(AZN.US)$ +78%
$NVM +45%
$Merck & Co(MRK.US)$ +37%
$ROCHE HOLDING AG(RHHBY.US)$ +27%
$Pfizer(PFE.US)$ +13%
$GlaxoSmithKline(GSK.US)$ +13%
----- $SPDR S&P 500 ETF(SPY.US)$ +12% -----
$Sanofi(SNY.US)$ +3%
Source: Arjun Murthy on the HR app!
Powell said a rate hike is unlikely. But he also admitted that inflation is lacking progress towards their 2%.
His speech sounded neutral to me.
The market reacted positively by spiking up, but the pop quickly faded, and we went back to the level before Powell’s speech.
$ARK 21Shares Bitcoin ETF(ARKB.US)$ $Super Micro Computer(SMCI.US)$ $Roku Inc(ROKU.US)$ $Arm Holdings(ARM.US)$ $Johnson & Johnson(JNJ.US)$ $Zoom Video Communications(ZM.US)$ $Walmart(WMT.US)$ $Target(TGT.US)$ $Nike(NKE.US)$ $Coca-Cola(KO.US)$ $PepsiCo(PEP.US)$ $XPeng(XPEV.US)$ $Merck & Co(MRK.US)$ $Baidu(BIDU.US)$ $AMC Entertainment(AMC.US)$ $GameStop(GME.US)$
Gapping up
$American Airlines(AAL.US)$ stock increased by 5.2% as the company predicted profits for the current quarter that are largely above expectations, fueled by a resurgence in business travel and the prospect of strong demand during the summer season.
$Ford Motor(F.US)$ stock climbed 1.1% due to robust first-quarter earnings, a strong showing from its commercial vehicle division, rising hybrid vehicle sale...
Next week's earnings reports from major technology companies might provide a boost to a weakening market, or at the very least, offer investors insight into future stock trends.
$Tesla(TSLA.US)$ is set to release its earnings on Tuesday, followed by $Meta Platforms(META.US)$ on Wednesday. The week continues with a significant day on Thursday, as $Alphabet-C(GOOG.US)$ , the parent company of Google...
No comment yet